Literature DB >> 28343588

Preoperative Biliary Drainage in Patients with Resectable Perihilar Cholangiocarcinoma: Is Percutaneous Transhepatic Biliary Drainage Safer and More Effective than Endoscopic Biliary Drainage? A Meta-Analysis.

Aimen Al Mahjoub1, Benjamin Menahem2, Audrey Fohlen3, Benoit Dupont4, Arnaud Alves2, Guy Launoy1, Jean Lubrano5.   

Abstract

PURPOSE: To determine the best initial procedure for performing preoperative biliary drainage in patients with resectable perihilar cholangiocarcinoma (PHCC).
MATERIALS AND METHODS: MEDLINE/PubMed and the Cochrane database were searched for all studies published until June 2016 comparing endoscopic biliary drainage (EBD) and percutaneous transhepatic biliary drainage (PTBD) for preoperative biliary drainage. Meta-analysis was performed by using Review Manager 5.3 software.
RESULTS: Four retrospective studies were identified that met the criteria. The analysis was performed on 433 patients who underwent preoperative biliary drainage for resectable PHCC. Of those, 275 (63.5%) had EBD and 158 (36.5%) had PTBD as the initial procedure. The overall procedure-related morbidity rate was significantly lower in the PTBD group than in the EBD group (39 of 147 [26.5%] vs 82 of 185 [44.3%]; odds ratio [OR], 2.23; 95% confidence interval [CI], 1.39-3.57; P = .0009). The rate of conversion from one procedure to the other was significantly lower in the PTBD group than in the EBD group (8 of 158 [5.0%] vs 73 of 275 [26.5%]; odds ratio, 4.76; 95% CI, 2.71-8.36; P < .00001). Pancreatitis occurred only in the EBD group (25 of 275 [9.0%] vs 0 of 158; OR, 7.46; 95% CI, 3.02-18.44; P < .0001). The cholangitis rate was significantly lower in the PTBD group than in the EBD group (12 of 158 [7.6%] vs 93 of 275 [33.8%]; OR, 5.41; 95% CI, 2.75-10.63; P < .00001).
CONCLUSIONS: This meta-analysis shows that PTBD has a lower rate of complications than EBD as the initial procedure to perform preoperative biliary drainage in resectable PHCC. PTBD is associated with less conversion and lower rates of pancreatitis and cholangitis.
Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28343588     DOI: 10.1016/j.jvir.2016.12.1218

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  19 in total

Review 1.  How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysis.

Authors:  Alessandro Rizzo; Angela Dalia Ricci; Giorgio Frega; Andrea Palloni; Stefania DE Lorenzo; Francesca Abbati; Veronica Mollica; Simona Tavolari; Mariacristina DI Marco; Giovanni Brandi
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  Association of preoperative biliary drainage technique with postoperative outcomes among patients with resectable hepatobiliary malignancy.

Authors:  Q Lina Hu; Jason B Liu; Ryan J Ellis; Jessica Y Liu; Anthony D Yang; Michael I D'Angelica; Clifford Y Ko; Ryan P Merkow
Journal:  HPB (Oxford)       Date:  2019-07-23       Impact factor: 3.647

3.  Effect of percutaneous transhepatic cholangial drainag + radiofrequency ablation combined with biliary stent implantation on the liver function of patients with cholangiocarcinoma complicated with malignant obstructive jaundice.

Authors:  Shuangyu Qi; Huijun Yan
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 4.  Role of Interventional Radiology in the Management of Acute Cholangitis.

Authors:  Pouya Entezari; Jonathan A Aguiar; Riad Salem; Ahsun Riaz
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

Review 5.  Treatment of Malignant Bile Duct Obstruction: What the Interventional Radiologist Needs to Know.

Authors:  Juan C Camacho; Lynn A Brody; Anne M Covey
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

Review 6.  Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.

Authors:  F Rassam; E Roos; K P van Lienden; J E van Hooft; H J Klümpen; G van Tienhoven; R J Bennink; M R Engelbrecht; A Schoorlemmer; U H W Beuers; J Verheij; M G Besselink; O R Busch; T M van Gulik
Journal:  Langenbecks Arch Surg       Date:  2018-01-19       Impact factor: 3.445

7.  Comparison of long-term efficacy between endoscopic and percutaneous biliary drainage for resectable extrahepatic cholangiocarcinoma with biliary obstruction: A systematic review and meta-analysis.

Authors:  Lei Wang; Nanping Lin; Fuli Xin; Yongyi Zeng; Jingfeng Liu
Journal:  Saudi J Gastroenterol       Date:  2019 Mar-Apr       Impact factor: 2.485

Review 8.  Surgery for cholangiocarcinoma.

Authors:  Umberto Cillo; Constantino Fondevila; Matteo Donadon; Enrico Gringeri; Federico Mocchegiani; Hans J Schlitt; Jan N M Ijzermans; Marco Vivarelli; Krzysztof Zieniewicz; Steven W M Olde Damink; Bas Groot Koerkamp
Journal:  Liver Int       Date:  2019-05       Impact factor: 5.828

9.  Management of biliary diseases after the failure of initial needle knife precut sphincterotomy for biliary cannulation.

Authors:  Min-Hao Lo; Cheng-Hui Lin; Chi-Huan Wu; Yung-Kuan Tsou; Mu-Hsien Lee; Kai-Feng Sung; Nai-Jen Liu
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

10.  Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma.

Authors:  Eva Braunwarth; Stefan Stättner; Margot Fodor; Benno Cardini; Thomas Resch; Rupert Oberhuber; Daniel Putzer; Reto Bale; Manuel Maglione; Christian Margreiter; Stefan Schneeberger; Dietmar Öfner; Florian Primavesi
Journal:  Eur Surg       Date:  2018-05-17       Impact factor: 0.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.